P2rx7tm1.1Vvc
Targeted Allele Detail
|
Symbol: |
P2rx7tm1.1Vvc |
Name: |
purinergic receptor P2X, ligand-gated ion channel, 7; targeted mutation 1.1, Valerie Vouret-Craviari |
MGI ID: |
MGI:6827300 |
Synonyms: |
p2rx7loxP |
Gene: |
P2rx7 Location: Chr5:122781974-122829495 bp, + strand Genetic Position: Chr5, 62.5 cM, cytoband F
|
Alliance: |
P2rx7tm1.1Vvc page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:301006
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
C57BL/6
|
|
Allele Type: |
|
Targeted (Conditional ready) |
Mutation: |
|
Insertion
|
|
|
Mutation details: ES clones (C57/BL/6) containing a construct for the conditional elimination or re-expression of P2RX7 (purchased from The European Conditional Mouse Mutagenesis Program) were injected into blastocytes of C57Bl6/N. The chimeric mice were selected and crossed with Flp deleter mice.
(J:301006)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any P2rx7 Mutation: |
52 strains or lines available
|
|
Original: |
J:301006 Douguet L, et al., A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy. Nat Commun. 2021 Jan 28;12(1):653 |
All: |
1 reference(s) |
|